Moreover, amplification of the gene encoding MET has been implicated in acquired resistance to the BRAF inhibitor vemurafenib in cultured melanoma cells (Vergani et al, 2011; Straussman et al, 2012). This evidence concerns the gene BRAF and melanoma.